BIOMAT Database Logo BIOMAT Database Logo

Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. 1995

C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
Institute of General and Experimental Pathology, University of Vienna, Austria.

The immune response toward allergens in nonallergic healthy individuals was investigated. To boost immune responses, two injections of birch pollen extract were administered to five nonallergic volunteers. T cell lines (TCL) with specificity for Bet v 1, the major birch pollen allergen, were established and analyzed for epitope specificity using overlapping peptides. Forty-nine T cell clones (TCC) specific for Bet v 1 were isolated from TCLs. Comparison with TCL and TCC established from birch pollen-allergic patients was performed. All TCC revealed the Th phenotype. Epitope specificities of TCL and TCC from nonatopics were identical to those found in allergic individuals. No association between MHC class II molecules and particular epitopes could be observed. In nonallergic as well as in allergic individuals, cytokine production in response to specific stimulation revealed a majority of Th-clones producing IL-4 and IFN-gamma. However, TCC derived from atopic individuals revealed a higher IL-4/IFN-gamma ratio. Immunoblot and ELISA revealed Bet v 1-specific IgG in nonallergic individuals before and after booster injections, but no IgE could be detected. High levels of Bet v 1-specific IgG and IgE could be detected in birch pollen-allergic patients. It can be concluded, that nonatopic and allergic individuals display the same repertoire of T cell specificities. In allergic individuals, the activation of allergen-specific TCC leads to a higher ratio of produced IL-4 vs IFN-gamma, which is responsible for enhanced IgE production.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007428 Intradermal Tests Skin tests in which the sensitizer is injected. Passive Transfer Test,Prausnitz-Kustner Test,Intradermal Test,Passive Transfer Tests,Prausnitz Kustner Test,Test, Intradermal,Test, Passive Transfer,Test, Prausnitz-Kustner,Tests, Intradermal,Tests, Passive Transfer
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010940 Plant Proteins Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which PLANT PROTEINS, DIETARY is available. Plant Protein,Protein, Plant,Proteins, Plant
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference

Related Publications

C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
IgE and allergen-specific immunotherapy-induced IgG4 recognize similar epitopes of Bet v 1, the major allergen of birch pollen.
May 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
The major birch pollen allergen, Bet v 1, shows ribonuclease activity.
January 1996, Planta,
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
January 2015, PloS one,
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms.
March 2019, The Journal of allergy and clinical immunology,
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
The History and Science of the Major Birch Pollen Allergen Bet v 1.
July 2023, Biomolecules,
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
Dynamics Rationalize Proteolytic Susceptibility of the Major Birch Pollen Allergen Bet v 1.
January 2020, Frontiers in molecular biosciences,
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides.
February 1993, Journal of immunology (Baltimore, Md. : 1950),
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
December 2000, Journal of immunology (Baltimore, Md. : 1950),
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 is Isoform Dependent.
January 2015, PloS one,
C Ebner, and S Schenk, and N Najafian, and U Siemann, and R Steiner, and G W Fischer, and K Hoffmann, and Z Szépfalusi, and O Scheiner, and D Kraft
High-level expression and purification of the major birch pollen allergen, Bet v 1.
February 1997, Protein expression and purification,
Copied contents to your clipboard!